Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia

Neoplasma

Volumn 53, Issue 4, 2006, Pages 269-276

  Zavodna, K ^a   Bujalkova, M ^a   Krivulcik, T ^a   Alemayehu, A ^a   Skorvaga, M ^a   Marra, G ^b   Fridrichova, I ^a   Jiricny, J ^b   Bartosova, Z ^a  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Germline mutations; HNPCC; MLH1; MSH2

Indexed keywords

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ETHNIC GROUP; EXON; FEMALE; FRAMESHIFT MUTATION; GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; INTRON; MALE; MISMATCH REPAIR; MISSENSE MUTATION; MLH 1 GENE; MSH 2 GENE; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOVAKIA;

EID: 33746318687     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. BARTOSOVA Z, FRIDRICHOVA I, BUJALKOVA M, WOLF B, ILENCIKOVA D et al. Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Hum Mutat 2003; 21(4): 449.
2. FRIDRICHOVA I, ILENCIKOVA D, FRIEDL W, HLAVCAK P, SKORVAGA M et al. Approaches to identification of HNPCC suspected patients in Slovak population. Neoplasma 2000; 47(4): 219-226.
3. ZAJAC V, KOVAC M, KIRCHHOFF T, STEVURKOVA V, TOMKA M. The most frequent APC mutations among Slovak familial adenomatous polyposis patients. Adenomatous polyposis coli. Neoplasma 2002; 49(6): 356-361.
4. CIERNIKOVA S, TOMKA M, SEDLAKOVA O, REINEROVA M, STEVURKOVA V et al. The novel exon 11 mutation of BRCA1 gene in a high-risk family. Neoplasma 2003; 50(6): 403-407.
5. CIERNIKOVA S, TOMKA M, KOVAC M, STEVURKOVA V, ZAJAC V. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Neoplasma 2006; 53(2): 97-102.
6. KOVAC M, TOMKA M, CIERNIKOVA S, STEVURKOVA V, VALACHOVA A et al. Multiple gynecologic tumors as rare associated phenotypes of FAP/Gardner syndrome in a family with the novel germline mutation in the APC gene. Clin Genet 2006; 69(2): 183-186.
7. POTURNAJOVA M, ALTANEROVA V, KOSTALOVA L, BREZA J, ALTANER C. Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A;syndrome. J Mol Med 2005; 83(4): 287-295.
8. DE LA CHAPELLE A. The incidence of Lynch syndrome. Fam Cancer 2005; 4(3): 233-237.
9. HLAVATY T, LUKAC L, DURIS I. Families at risk of colon cancer;II. Hereditary nonpolyposis colorectal carcinoma. Vnitr Lek 2004 50(8): 606-614.
10. WATSON P, RILEY B. The tumor spectrum in the Lynch syndrome. Fam Cancer 2005; 4(3): 245-248.
11. PELTOMAKI P. Lynch syndrome genes. Fam Cancer 2005; 4(3): 227-232.
12. GIRALDO A, GOMEZ A, SALGUERO G, GARCIA H, ARISTIZABAL F et al. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)-description of four novel mutations. Fam Cancer 2005; 4(4): 285-290.
13. MANGOLD E, PAGENSTECHER C, FRIEDL W, MATHIAK M, BUETTNER R et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 2005; 116(5): 69200-702.
14. KRUGER S, BIER A, PLASCHKE J, HOHL R, AUST DE et al. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC. Hum Mutat 2004; 24(4): 351-352.
15. VASEN HFA. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. Fam Cancer 2005; 4(3): 219-225.
16. DESAI DC, LOCKMAN JC, CHADWICK RB, GAO X, PERCESEPE A et al. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 2000; 37(9): 646-652.
17. DEN DUNNEN JT, ANTONARAKIS SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000; 15(1): 7-12.
18. DEN DUNNEN JT, ANTONARAKIS SE. Nomenclature for the description of human sequence variations. Hum Genet 2001; 109(1): 121-124.
19. DEN DUNNEN JT, PAALMAN MH. Standardizing mutation nomenclature: why bother? Hum Mutat 2003; 22(3): 181-182.
20. NYSTROM-LAHTI M, WU Y, MOISIO AL, HOFSTRA RM, OSINGA J et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996; 5(6): 763-769.
21. STENSON PD, BALL EV, MORT M, PHILLIPS AD, SHIEL JA, THOMAS NS et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21(6): 577-581.
22. GREEN RC, GREEN AG, SIMMS M, PATER A, ROBB JD et al. Germline hMLH1 promoter mutation in a Newfoundland HNPCC kindred. Clin Genet 2003; 64(3)0: 220-227.
23. ITO E, YANAGISAWA Y, IWAHASHI Y, SUZUKI Y, NAGASAKI H et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 1999; 256 (3): 488-494.
24. RENKONEN E, LOHI H, JARVINEN HJ, MECKLIN JP, PELTOMAKI P. Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations. J Med Genet 2004; 41(7): e95.
25. CALUSERIU O, CORDISCO EL, VIELA, MAJORE S, NASCIMBENI R et al. Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer. Hum Mutat 2001; 17(6): 521.
26. STONE JG, COLEMAN G, GUSTERSON B, MAROSSY A, LAKHANI SR et al. Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast. Cancer Lett 2001; 167(2): 171-174.
27. VASEN HF, MORREAU H, NORTIER JW. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001; 68(6): 1533-1535.
28. MULLER A, EDMONSTON TB, CORAO DA, ROSE DG, PALAZZO JP et al. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62(4): 1014-1019.
29. SCOTT RJ, ASHTON KA. Familial and breast and bowel cancer: Does it exist? Hereditary Cancer in Clinical Practice 2004; 2(1): 25-29.
30. MALIAKA YK, CHUDINA AP, BELEV NF, ALDAY P, BOCHKOV NP et al. C0pG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations. Hum Genet 1996; 97(2): 251-255.
31. PLEVOVA P, KREPELOVA A, PAPEZOVA M, SEDLAKOVA E, CURIK R et al. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer. Neoplasma 2004; 51(4): 275-284.
32. VIEL A, GENUARDI M, CAPOZZI E, LEONARDI F, BELLACOSA A et al. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer 1997; 18(1): 8-18.
33. BAN C, JUNOP M, YANG W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 1999; 97(1): 85-97.
34. JUNOP MS, YANG W, FUNCHAIN P, CLENDENIN W, MILLER JH. In vitro and in vivo studies of MutS, MutL and MutH mutants: correlation of mismatch repair and DNA recombination. DNA Repair (Amst) 2003; 2(4): 387-405.
35. KONDO E, HORII A, FUKUSHIGE S. The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2. Nucleic Acids Res 2001; 29(8): 1695-1702.
36. TROJAN J, RAEDLE J, ZEUZEM S. Pathogenetic germ-line mutation in patients with hereditary nonpolyposis colorectal carcinoma (HNPCC). Z Gastroenterol 1999; 37(4): 321-324.
37. DIEUMEGARD B, GRANDJOUAN S, SABOURIN JC, LE BIHAN ML, LEFRERE I et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000; 82(4): 871-880.
38. KURZAWSKI G, SUCHY J, KLADNY J, SAFRANOW K, JAKUBOWSKA A et al. Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States. J Med Genet 2002; 39(10): E65.
39. KURZAWSKI G, SUCHY J, LENER M, KLUJSZO-GRABOWSKA E, KLADNY J et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet 2006; 69(1): 40-47.
40. VIEL A, PETRONZELLI F, DELLA PUPPA L, LUCCI-CORDISCO E, FORNASARIG M et al. Different molecular mechanisms underlie genomic deletions in the MLH1 Gene. Hum Mutat 2002; 20(5): 368-374.
41. CHARBONNIER F, OLSCHWANG S, WANG Q, BOISSON C, MARTIN C et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002; 62(3): 848-853.
42. WANG Y, FRIEDL W, LAMBERTI C, JUNGCK M, MATHIAK M et al. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003; 103(5): 636-641.
43. DI FIORE F, CHARBONNIER F, MARTIN C, FREROT S, OLSCHWANG S et al. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet 2004; 41(1): 18-20.
44. SCHOUTEN JP, MCELGUNN CJ, WAAIJER R, ZWIJNENBURG D, DIEPVENS F et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30(12): e57.